Pharmaceutical
| Fri 03 Jul 2026
Geneva, July 4 -- Univ Duke, Univ North Carolina Chapel Hill, Univ Leland Stanford Junior and Icahn School of Medicine, Mount Sinai have sought patent for Heterocyclic Compounds as 5ht2a Biased Agonists. This invention was developed by Gumpper Ryan, Jain Manish, Dror Ron, Qian Chao, Xu Zhongli, Jin Jian, Roth Bryan, Suomivuori C..